SwissMedic-2021-0089-V189
Type II variation for application SwissMedic-2021-0089. Type II variation: Formulation Change for Raredimab — minor update
Variation Number
SwissMedic-2021-0089-V189
Type
Type II
Application
Change
Status
Blocked
Fee
€38,629
Submitted
—
Approved
—
Description
Type II variation: Formulation Change for Raredimab — minor update